Join
Live feed
·
NEWSReleasevia Quantisnow
Orion Biotech Opportunities Corp. logo

Orion Biotech Opportunities Says Will Redeem Public Share, Will Not Consummate Initial Business Combination

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ORIA (Orion Biotech Opportunities Corp.) and more on Quantisnow.